Four-weekly infliximab in the treatment of severe hidradenitis suppurativa

B. Moriarty; Z. Jiyad; Daniel Creamer

doi:10.1111/bjd.12713

Four-weekly infliximab in the treatment of severe hidradenitis suppurativa

B. Moriarty^*, Z. Jiyad, Daniel Creamer

^*Corresponding author for this work

KCH King's College Hospital NHS Foundation Trust

Research output: Contribution to journal › Letter › peer-review

41 Citations (Scopus)

Original language	English
Pages (from-to)	986-987
Number of pages	2
Journal	British Journal of Dermatology
Volume	170
Issue number	4
DOIs	https://doi.org/10.1111/bjd.12713
Publication status	Published - Apr 2014

Keywords

ADALIMUMAB
MODERATE
TRIAL

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bjd.12713

Cite this

@article{96091d04a00c4c8bb851cc5dcf30514b,

title = "Four-weekly infliximab in the treatment of severe hidradenitis suppurativa",

keywords = "ADALIMUMAB, MODERATE, TRIAL",

author = "B. Moriarty and Z. Jiyad and Daniel Creamer",

year = "2014",

month = apr,

doi = "10.1111/bjd.12713",

language = "English",

volume = "170",

pages = "986--987",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "John Wiley & Sons, Ltd (10.1111)",

number = "4",

}

TY - JOUR

T1 - Four-weekly infliximab in the treatment of severe hidradenitis suppurativa

AU - Moriarty, B.

AU - Jiyad, Z.

AU - Creamer, Daniel

PY - 2014/4

Y1 - 2014/4

KW - ADALIMUMAB

KW - MODERATE

KW - TRIAL

U2 - 10.1111/bjd.12713

DO - 10.1111/bjd.12713

M3 - Letter

SN - 0007-0963

VL - 170

SP - 986

EP - 987

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 4

ER -